title: Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making.
authors.affiliation: Division of Molecular Medicine, Millennium Pharmaceuticals, Cambridge, MA 02139, USA. wtrepicchio@mpi.com
authors.forename: W L
authors.initials: WL
authors.lastname: Trepicchio
authors.forename: D
authors.initials: D
authors.lastname: Essayan
authors.forename: S T
authors.initials: ST
authors.lastname: Hall
authors.forename: G
authors.initials: G
authors.lastname: Schechter
authors.forename: Z
authors.initials: Z
authors.lastname: Tezak
authors.forename: S J
authors.initials: SJ
authors.lastname: Wang
authors.forename: D
authors.initials: D
authors.lastname: Weinreich
authors.forename: R
authors.initials: R
authors.lastname: Simon
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D003657:Decision Making; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000379:methods / Q000592:standards; D006801:Humans; D010597:Pharmacogenetics; D011446:Prospective Studies; D012107:Research Design